Mariner, LLC Laboratory Corp Of America Holdings Transaction History

Mariner, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$209.01 - $232.56 $1,463 - $1,627	-7 Reduced 0.07%	9,945 $2.17 Million
Q4 2023 Feb 14, 2024	BUY	$197.69 - $227.29 $182,863 - $210,243	925 Added 10.25%	9,952 $2.26 Million
Q3 2023 Nov 13, 2023	BUY	$201.05 - $221.7 $190,997 - $210,615	950 Added 11.76%	9,027 $1.81 Million
Q2 2023 Aug 11, 2023	BUY	$211.93 - $241.33 $39,418 - $44,887	186 Added 2.36%	8,077 $1.95 Million
Q1 2023 May 12, 2023	BUY	$213.32 - $257.83 $40,744 - $49,245	191 Added 2.48%	7,891 $1.81 Million
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $105,323 - $128,717	517 Added 7.2%	7,700 $1.81 Million
Q3 2022 Nov 10, 2022	BUY	$204.81 - $262.19 $1.47 Million - $1.88 Million	7,183 New	7,183 $1.47 Million
Q3 2019 Nov 13, 2019	SELL	$159.77 - $178.1 $304,042 - $338,924	-1,903 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$144.16 - $172.9 $33,445 - $40,112	232 Added 13.88%	1,903 $329,000
Q1 2019 May 15, 2019	BUY	$123.7 - $156.3 $206,702 - $261,177	1,671 New	1,671 $256,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.